| Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy (NCT00052845) | Alliance for Clinical Trials in Oncology | 2002-11-01 |
| Functional and Morphologic MRI in the Detection of Prostate Cancer in Patients With Prior Negative Biopsy (NCT00242060) | University Health Network, Toronto | 2002-11-01 |
| Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer (NCT00043069) | Alliance for Clinical Trials in Oncology | 2002-11-01 |
| Isotretinoin, Interferon Alfa-2b, Docetaxel, and Estramustine in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy (NCT00176527) | University of Medicine and Dentistry of New Jersey | 2002-11-01 |
| Comparison Study of MDX-010 (CTLA-4) Alone and Combined With Docetaxel in the Treatment of Patients With Hormone Refractory Prostate Cancer (NCT00050596) | Bristol-Myers Squibb | 2002-11-01 |
| A Trial of MLN2704 in Subjects With Metastatic Androgen Independent Prostate Cancer (NCT00052000) | Millennium Pharmaceuticals, Inc. | 2002-11-01 |
| Intensity-Modulated Radiation Therapy in Treating Patients With Localized Prostate Cancer (NCT00392535) | Institute of Cancer Research, United Kingdom | 2002-10-18 |
| Phase I/II Hypofractionated Radiotherapy for Prostate Cancer (NCT00214097) | University of Wisconsin, Madison | 2002-10-14 |
| Open-label Phase IV Clinical Trial to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastases (NCT00242554) | Novartis Pharmaceuticals | 2002-10-01 |
| Celecoxib (Celebrex) Versus Placebo in Men With Recurrent Prostate Cancer (NCT00136487) | Dana-Farber Cancer Institute | 2002-10-01 |
| Extension Study Investigating the Long-Term Safety and Tolerability of Repeat Doses of FE200486 in Prostate Cancer Patients (NCT00117312) | Ferring Pharmaceuticals | 2002-10-01 |
| A Pilot Study Evaluating Oral Triamcinalone in Patients With Androgen Independent Prostate Cancer (NCT00186108) | Stanford University | 2002-10-01 |
| Angelica Sinensis for the Treatment of Hot Flashes in Men Undergoing LHRH Therapy for Prostate Cancer (NCT00199485) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2002-10-01 |
| Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer (NCT00030654) | Radiation Therapy Oncology Group | 2002-10-01 |
| Paclitaxel and Carboplatin in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy (NCT00049257) | Jonsson Comprehensive Cancer Center | 2002-10-01 |
| Psychostimulants for Fatigue in Prostate Cancer (NCT00138138) | Memorial Sloan Kettering Cancer Center | 2002-10-01 |
| Immunotherapy After Chemotherapy for Patients With Hormone Refractory Metastatic Prostate Cancer (NCT00283829) | University of Washington | 2002-09-01 |
| Atrasentan in Treating Patients With Prostate Cancer (NCT00046943) | Abbott | 2002-09-01 |
| Docetaxel in Treating Older Patients With Metastatic Breast, Lung, or Prostate Cancer (NCT00059943) | Memorial Sloan Kettering Cancer Center | 2002-09-01 |
| Calcitriol and Dexamethasone Before Radical Prostatectomy in Treating Patients With Localized Adenocarcinoma (Cancer) of the Prostate (NCT00084864) | Roswell Park Cancer Institute | 2002-09-01 |
| Quality of Life in Patients Undergoing Surgery or Brachytherapy for Stage II Prostate Cancer (NCT00052481) | Alliance for Clinical Trials in Oncology | 2002-09-01 |
| Quality of Life Following Radical Prostatectomy (NCT00373308) | Stanford University | 2002-09-01 |
| Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer (NCT02749825) | Pharmatech | 2002-09-01 |
| Acupuncture in Treating Hot Flashes in Patients With Prostate Cancer (NCT00244894) | OHSU Knight Cancer Institute | 2002-09-01 |
| CD-ROM Intervention for Prostate Cancer Screening (NCT00164437) | Centers for Disease Control and Prevention | 2002-09-01 |
| Vaccine Therapy With or Without Docetaxel in Treating Patients With Metastatic Prostate Cancer (NCT00045227) | National Cancer Institute (NCI) | 2002-08-01 |
| Study in Predicting Outcome of Patients Undergoing Radiation Therapy for Prostate Cancer (NCT00045331) | National Cancer Institute (NCI) | 2002-08-01 |
| A Phase II Trial of Combination Therapy With Celecoxib and Taxotere for the Treatment of Stage D3 Prostate Cancer (NCT00215345) | Department of Veterans Affairs, New Jersey | 2002-08-01 |
| ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere (NCT00043576) | Novacea | 2002-08-01 |
| Selenium in Treating Patients With Prostate Cancer (NCT00752739) | University of Arizona | 2002-08-01 |
| Collection of Blood From Patients With Cancer (NCT00034216) | National Cancer Institute (NCI) | 2002-07-16 |
| A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer (NCT00218205) | Department of Veterans Affairs, New Jersey | 2002-07-01 |
| Isoflavones & Lycopene in Localized Prostate Ca:Prior to Radical Prostatectomy (NCT00042731) | H. Lee Moffitt Cancer Center and Research Institute | 2002-07-01 |
| Diet and Exercise-Based Counseling Program Compared With a Standard Counseling Program in Patients With Early-Stage Prostate Cancer (NCT00044980) | Duke University | 2002-07-01 |
| Survey of Prostate Cancer in Accra, Ghana (NCT00339534) | National Cancer Institute (NCI) | 2002-06-26 |
| Magnetic Resonance-Guided High-Dose Brachytherapy (Short-Range Radiation Therapy) for Prostate Cancer (NCT00039624) | National Cancer Institute (NCI) | 2002-06-03 |
| ET 743 (Yondelis) in Men With Advanced Prostate Cancer (NCT00147212) | Massachusetts General Hospital | 2002-06-01 |
| Comparison of Two Radiation Therapy Regimens in Treating Patients With Stage II or Stage III Prostate Cancer (NCT00062309) | Fox Chase Cancer Center | 2002-06-01 |
| Longitudinal Assessment of Health-Related Quality of Life in Men With Localized Prostate Cancer (NCT00582842) | Memorial Sloan Kettering Cancer Center | 2002-05-14 |
| Prostate Biomarkers in Men Consuming Tomato Products (NCT02292524) | Ohio State University Comprehensive Cancer Center | 2002-05-01 |
| Prevention of Osteoporosis in Men With Prostate Cancer (NCT00048841) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2002-05-01 |
| Isoflavones and Radiation Therapy in Treating Patients With Localized Prostate Cancer (NCT00243048) | Barbara Ann Karmanos Cancer Institute | 2002-05-01 |
| Celecoxib Compared With No Treatment Before Surgery in Treating Patients With Localized Prostate Cancer (NCT00022399) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2002-04-25 |
| Survival Outcomes and Tumor Molecular Profile Following Bicalutamide Neoadjuvant Therapy (NCT00418080) | University of L'Aquila | 2002-04-01 |
| Study Investigating the Pharmacokinetics, Pharmacodynamics and Safety of FE200486 (NCT00117949) | Ferring Pharmaceuticals | 2002-04-01 |
| Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer Who Have Undergone Surgery or Radiation Therapy (NCT00054522) | Roswell Park Cancer Institute | 2002-04-01 |
| Study of Docetaxel With Doxercalciferol or Placebo for Advanced Prostate Cancer (NCT00582582) | University of Wisconsin, Madison | 2002-04-01 |
| Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer (NCT00024167) | M.D. Anderson Cancer Center | 2002-04-01 |
| Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis (NCT00033605) | Alliance for Clinical Trials in Oncology | 2002-04-01 |
| Open-label Trial on the Effect of I.V. Zoledronic Acid 4 mg on Bone Density in Hormone Sensitive Prostate Cancer Patients With Bone Metastasis (NCT00035997) | Novartis Pharmaceuticals | 2002-04-01 |
| Study of Health Promotion in Patients With Early-Stage Breast or Prostate Cancer (NCT00037024) | Duke University | 2002-04-01 |
| Exisulind and Intermittent Androgen Suppression (ADT) in Biochemical Relapsed Prostate Cancer (NCT00283803) | University of Washington | 2002-03-12 |
| Radiation Therapy in Treating Patients With Stage II Prostate Cancer (NCT00033631) | Radiation Therapy Oncology Group | 2002-03-01 |
| Vaccine Therapy Plus QS21 in Treating Patients With Prostate Cancer (NCT00036933) | Memorial Sloan Kettering Cancer Center | 2002-03-01 |
| Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate Cancer (NCT00681694) | Massachusetts General Hospital | 2002-03-01 |
| Safety and Effectiveness of a Vaccine for Prostate Cancer That Uses Each Patients' Own Immune Cells. (NCT00289341) | Rockefeller University | 2002-03-01 |
| Intensity-Modulated Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Prostate Cancer (NCT00653757) | Mayo Clinic | 2002-03-01 |
| Biological Therapy in Treating Patients With Prostate Cancer (NCT00039299) | Jonsson Comprehensive Cancer Center | 2002-03-01 |
| Prostate Cancer Screening and Dietary Heterocyclic Amines in African American Men (NCT00354497) | Lawrence Livermore National Laboratory at University of California | 2002-03-01 |
| Assessing Quality of Life of Patients With Prostate Cancer (NCT00041301) | European Organisation for Research and Treatment of Cancer - EORTC | 2002-03-01 |
| Trial of Vaccine Therapy With mRNA- Transfected Dendritic Cells in Patients With Androgen Resistant Metastatic Prostate Cancer (NCT01278914) | Oslo University Hospital | 2002-02-01 |
| Hormone Therapy Followed By Internal Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer (NCT00032006) | Alliance for Clinical Trials in Oncology | 2002-02-01 |
| The Specific Role of Isoflavones in Reducing Prostate Cancer Risk (NCT00617617) | H. Lee Moffitt Cancer Center and Research Institute | 2002-02-01 |
| R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence (NCT00045123) | Myrexis Inc. | 2002-02-01 |
| Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer (NCT00036790) | University of Wisconsin, Madison | 2002-02-01 |
| Doxorubicin and Strontium-89 With or Without Celecoxib in Treating Patients With Progressive Androgen-Independent Prostate Cancer and Bone Metastases (NCT00080782) | M.D. Anderson Cancer Center | 2002-02-01 |
| Hormone Therapy With or Without Squalamine Lactate in Treating Patients Who Are Undergoing a Radical Prostatectomy for Locally Advanced Prostate Cancer (NCT00244920) | OHSU Knight Cancer Institute | 2002-01-01 |
| Study of Tissue, Blood, and Urine Samples From Patients With Advanced Prostate Cancer (NCT00967889) | Cancer Research UK | 2002-01-01 |
| Low-Fat Fish Oil Diet for Prostate Cancer Prevention (NCT00798876) | Jonsson Comprehensive Cancer Center | 2001-12-18 |
| Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer (NCT00028574) | Alliance for Clinical Trials in Oncology | 2001-12-01 |
| S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer (NCT00028769) | SWOG Cancer Research Network | 2001-12-01 |
| APC8015 and Bevacizumab in Treating Patients With Prostate Cancer (NCT00027599) | National Cancer Institute (NCI) | 2001-12-01 |
| Atrasentan and Zometa for Men With Prostate Cancer Metastatic to Bone (NCT00181558) | Massachusetts General Hospital | 2001-12-01 |
| Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate Cancer (NCT00151086) | University of Michigan Rogel Cancer Center | 2001-12-01 |
| Dose Escalation and Efficacy Trial of GVAX® Prostate Cancer Vaccine (NCT00140348) | Cell Genesys | 2001-12-01 |
| Vitamin E, Selenium, and Soy Protein in Preventing Cancer in Patients With High-Grade Prostate Neoplasia (NCT00064194) | NCIC Clinical Trials Group | 2001-11-28 |
| Soy Isoflavones in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage I or Stage II Adenocarcinoma of the Prostate (NCT00078923) | Barbara Ann Karmanos Cancer Institute | 2001-11-01 |
| Vaccine Therapy Plus Interleukin-12 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy (NCT00015977) | University of Chicago | 2001-11-01 |
| Neoadjuvant Eflornithine and Bicalutamide Compared With Eflornithine Alone, Bicalutamide Alone, and No Neoadjuvant Therapy in Treating Patients With Localized Prostate Cancer Undergoing Brachytherapy or Radical Prostatectomy (NCT00086736) | University of Alabama at Birmingham | 2001-11-01 |
| SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer (NCT00026377) | University of Chicago | 2001-11-01 |
| A Phase II Trial of Adjuvant Docetaxel in Patients At High Risk of Relapse Following Prostatectomy (NCT00069888) | Sanofi | 2001-11-01 |
| High-Intensity Focused Ultrasound in Treating Patients With Locally Recurrent Prostate Cancer (NCT00030277) | Focus Surgery | 2001-10-01 |
| PROvenge Treatment and Early Cancer Treatment (NCT00779402) | Dendreon | 2001-10-01 |
| Surgery Versus Internal Radiation in Treating Patients With Stage II Prostate Cancer (NCT00023686) | Alliance for Clinical Trials in Oncology | 2001-10-01 |
| Study Investigating the Long-Term Safety and Tolerability of Repeated Doses of Degarelix in Prostate Cancer Patients (NCT00245466) | Ferring Pharmaceuticals | 2001-10-01 |
| Treatment With Zoledronic Acid in Patients With Breast Cancer, Multiple Myeloma, and Prostate Cancer With Cancer Related Bone Lesions (NCT00029224) | Novartis | 2001-10-01 |
| Ultrasound in Treating Patients With Prostate Cancer Confined to the Prostate (NCT00030290) | Focus Surgery | 2001-10-01 |
| Phase I Trial of Fixed Dose STI571 (Imatinib Mesylate) With Escalating Doses of Docetaxel in Patients With Metastatic Androgen-Independent Prostate Cancer (NCT00038194) | M.D. Anderson Cancer Center | 2001-10-01 |
| The Potential Use of BOLD MRI as a Noninvasive Measure of Tumor Hypoxia in Prostate Cancer (NCT00242073) | University Health Network, Toronto | 2001-10-01 |
| Radical Prostatectomy in Treating Patients With Locally Advanced Prostate Cancer (NCT00027794) | European Organisation for Research and Treatment of Cancer - EORTC | 2001-09-01 |
| Docetaxel, Estramustine, and Thalidomide in Treating Patients With Prostate Cancer Previously Treated With Hormone Therapy (NCT00046826) | Nuvance Health | 2001-09-01 |
| Prostate Cancer: Family Care for Patients and Spouses (NCT00708968) | University of Michigan | 2001-09-01 |
| Exemestane With or Without Bicalutamide in Treating Patients With Stage IV Prostate Cancer (NCT00031889) | Swiss Cancer Institute | 2001-08-01 |
| Low-Fat, High-Fiber Diet Compared to a Standard Diet in Treating Patients With Prostate Cancer (NCT00020995) | Jonsson Comprehensive Cancer Center | 2001-08-01 |
| Adjuvant Radiation Therapy Plus Hormone Therapy Compared With Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer (NCT00023829) | Radiation Therapy Oncology Group | 2001-08-01 |
| MEN-10755 in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy (NCT00027781) | European Organisation for Research and Treatment of Cancer - EORTC | 2001-08-01 |
| Nerve-Sparing Radical Prostatectomy With or Without Nerve Grafting Followed by Standard Therapy for Erectile Dysfunction in Treating Patients With Localized Prostate Cancer (NCT00080808) | M.D. Anderson Cancer Center | 2001-08-01 |
| Doxercalciferol Before Surgery in Treating Localized Prostate Cancer (NCT00022412) | University of Wisconsin, Madison | 2001-08-01 |
| Study Using CP-461 to Treat Advanced Prostate Cancer (NCT00036075) | Astellas Pharma Inc | 2001-08-01 |
| Analysis of Prostate Cancer Short-Term Cultures Using Molecular Cytogenetic Methods (NCT00022919) | National Human Genome Research Institute (NHGRI) | 2001-08-01 |